MedTrace Logo

Effect of Montelukast on Basophils, In-vitro

NCT00710450 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2011-09-23

No results posted yet for this study

Summary

Subjects with either allergic asthma or allergic rhinitis will be recruited to obtain blood. This blood will be used to be stimulated with to whatever the patient allergic. In the laboratory, this stimulated blood will be measured for histamine, leukotrienes, IL-13 and IL-3. These are chemicals responsible for allergy symptoms.

Conditions

  • Allergic Asthma
  • Allergic Rhinitis

Sponsors & Collaborators

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00710450 on ClinicalTrials.gov